NO20044709L - Kombinasjonsterapi mot tumorer omfattende substituerte akryloyldistamycinderivater og rontgenbehandling - Google Patents

Kombinasjonsterapi mot tumorer omfattende substituerte akryloyldistamycinderivater og rontgenbehandling

Info

Publication number
NO20044709L
NO20044709L NO20044709A NO20044709A NO20044709L NO 20044709 L NO20044709 L NO 20044709L NO 20044709 A NO20044709 A NO 20044709A NO 20044709 A NO20044709 A NO 20044709A NO 20044709 L NO20044709 L NO 20044709L
Authority
NO
Norway
Prior art keywords
distamycin derivatives
against tumors
acryloyl distamycin
therapy
substituted acryloyl
Prior art date
Application number
NO20044709A
Other languages
English (en)
Norwegian (no)
Inventor
Camilla Fowst
Maria Cristina Rosa Geroni
Jennifer Margaret Tursi
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of NO20044709L publication Critical patent/NO20044709L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
NO20044709A 2002-04-02 2004-11-01 Kombinasjonsterapi mot tumorer omfattende substituerte akryloyldistamycinderivater og rontgenbehandling NO20044709L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076240 2002-04-02
PCT/EP2003/003192 WO2003082267A1 (en) 2002-04-02 2003-03-17 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy

Publications (1)

Publication Number Publication Date
NO20044709L true NO20044709L (no) 2004-12-30

Family

ID=28459529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044709A NO20044709L (no) 2002-04-02 2004-11-01 Kombinasjonsterapi mot tumorer omfattende substituerte akryloyldistamycinderivater og rontgenbehandling

Country Status (19)

Country Link
US (1) US20110166077A9 (de)
EP (1) EP1490053B1 (de)
JP (1) JP2005527552A (de)
KR (1) KR100968657B1 (de)
CN (1) CN1302777C (de)
AT (1) ATE383154T1 (de)
AU (1) AU2003219102B2 (de)
BR (1) BR0308976A (de)
CA (1) CA2481005C (de)
DE (1) DE60318561T2 (de)
ES (1) ES2299692T3 (de)
IL (2) IL164356A0 (de)
MX (1) MXPA04009542A (de)
NO (1) NO20044709L (de)
NZ (1) NZ535700A (de)
PL (1) PL373998A1 (de)
RU (1) RU2314807C2 (de)
WO (1) WO2003082267A1 (de)
ZA (1) ZA200407948B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015446D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
CA2519289A1 (en) * 2003-03-18 2004-09-30 Antonino Suarato Nemorubicin as radiosensitizer in combination with radiation therapy against tumors
ATE447950T1 (de) * 2005-04-08 2009-11-15 Nerviano Medical Sciences Srl Antitumorale kombination aus substituierten acryloyldistamycin-derivaten und wachstumsfaktoren oder ihre rezeptoren hemmende antikörper
RU2478374C1 (ru) * 2012-02-06 2013-04-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Минздравсоцразвития России Способ внутриполостной терапии при лечении больных с метастазами рака во влагалище

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012321A1 (en) * 1989-03-31 1990-10-18 The Cancer Institute Board Halogenated dna ligand radiosensitisers for cancer therapy
JPH0925268A (ja) * 1995-07-12 1997-01-28 Taiho Yakuhin Kogyo Kk ２−ニトロイミダゾール誘導体
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
US6331286B1 (en) * 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
AU4079999A (en) * 1998-05-15 1999-12-06 Imclone Systems Incorporated Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
US6498181B1 (en) * 1999-01-06 2002-12-24 Maxim Pharmaceuticals Synergistic tumorcidal response induced by histamine
US6576759B2 (en) * 1999-02-10 2003-06-10 Pangene Corporation Antisense inhibition of RAD51
GB0011059D0 (en) * 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015447D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
US6576612B1 (en) * 2000-10-02 2003-06-10 Pharmacia Italia S.P.A. Antitumor therapy comprising distamycin derivatives

Also Published As

Publication number Publication date
HK1079116A1 (en) 2006-03-31
PL373998A1 (en) 2005-09-19
CN1302777C (zh) 2007-03-07
DE60318561T2 (de) 2009-01-08
WO2003082267A1 (en) 2003-10-09
JP2005527552A (ja) 2005-09-15
MXPA04009542A (es) 2005-01-25
KR20040101379A (ko) 2004-12-02
ZA200407948B (en) 2006-08-30
IL164356A0 (en) 2005-12-18
IL164356A (en) 2010-11-30
AU2003219102A1 (en) 2003-10-13
CN1649583A (zh) 2005-08-03
RU2314807C2 (ru) 2008-01-20
EP1490053A1 (de) 2004-12-29
RU2004131860A (ru) 2005-04-10
DE60318561D1 (de) 2008-02-21
BR0308976A (pt) 2005-01-11
CA2481005A1 (en) 2003-10-09
CA2481005C (en) 2009-06-09
ATE383154T1 (de) 2008-01-15
EP1490053B1 (de) 2008-01-09
NZ535700A (en) 2007-06-29
ES2299692T3 (es) 2008-06-01
US20110166077A9 (en) 2011-07-07
AU2003219102B2 (en) 2008-05-08
KR100968657B1 (ko) 2010-07-06
US20050143315A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
TW200501960A (en) Synergistic kits and compositions for treating cancer
TW200612918A (en) Lonidamine analogs
AP1913A (en) Substituted benzazoles and use thereof as raf kinase inhibitors
DK1372650T3 (da) Kombinationer indeholdende et antidiarrémiddel og en epothilon eller et epothilonderivat
CY1106766T1 (el) Παραγωγα πυριδινης ως αναστολεις raf κινασης
IT1333697B (de)
MY138059A (en) Use of ikb-kinase inhibitors in pain therapy
DK1853250T3 (da) Kombinationer og måder til indgivelse af terapeutiske midler og kombinationsterapi
NO20054988D0 (no) Preparater og metoder for behandling av cancer
NO20050427L (no) Carvedilolfosfatsalter og/eller solvater derav, tilsvarende preparater og/eller behandlingsfremgangsmater
NO20053817D0 (no) Preparater og fremgangsmater for antiviral kombinasjonsterapi.
ATE461217T1 (de) Glp-1-verbindungen
EP2267454A3 (de) Diagnose und Behandlung der Invasion von Krebszellen
PL1682126T3 (pl) Podstawione benzazole i ich zastosowanie jako inhibitorów kinazy Raf
WO2002046477A3 (en) Endogenous retroviruses up-regulated in prostate cancer
DK2263694T3 (da) Antitumormiddel omfattende histon-deacetylase-inhibitoren FK228 og topoisomerase-II-inhibitoren doxorubicin
MXPA05012421A (es) Tratamiento sinergistico de cancer usando inmunomeros junto con agentes quimioterapeuticos.
ATE411981T1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
NO20053903L (no) Nukleotidlipidesterderivater.
IL164356A0 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
TR200102557T2 (tr) Tiazonlindolinon bileşikleri.
MXPA05002477A (es) Asialo-interferones y el tratamiento de cancer de higado.
ATE491457T1 (de) Kombinationstherapie gegen tumoren mit substituierten acryloyl-distamycin-derivaten, taxanen und/oder antimetaboliten
AU2003229876A1 (en) Tumour associated antigens
AU2003288263A1 (en) Use of substituted acrylolyl distamycin derivatives in combination with demethylating agents, in the treatment of cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application